Cannassure Therapeutics Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
CSURE
IL0001110134
Healthcare Facilities & Services
Sales 2022 | 33.78 124.32 2.82K | Sales 2023 | 11 40.47 917.81 | Capitalization | 4M 14.72M 334M |
---|---|---|---|---|---|
Net income 2022 | -5M -18.4M -417M | Net income 2023 | -1M -3.68M -83.45M | EV / Sales 2022 | 10,23,292 x |
Net Debt 2022 | 29.96M 110M 2.5B | Net Debt 2023 | 2.43M 8.96M 203M | EV / Sales 2023 | 5,85,038 x |
P/E ratio 2022 |
-0.84
x | P/E ratio 2023 |
-2.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 101.78% |
Managers | Title | Age | Since |
---|---|---|---|
Ada Bar Kama
CEO | Chief Executive Officer | 54 | 31/22/31 |
Nir Peles
CHM | Chairman | 51 | 04/18/04 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 26/19/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shimon Bar-Kama
BRD | Director/Board Member | 71 | 04/18/04 |
Nir Peles
CHM | Chairman | 51 | 04/18/04 |
Varda Kalal
BRD | Director/Board Member | 56 | 14/22/14 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 339M | |
+35.05% | 289M | |
+41.15% | 280M | |
+46.51% | 188M | |
+144.22% | 146M | |
+47.11% | 136M | |
-37.75% | 129M | |
-28.57% | 121M | |
+7.69% | 97.22M |